These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 15577606)
21. Autoantibodies to intracellular antigens, with particular reference to transfer RNA and related proteins in myositis. Bernstein RM; Mathews MB J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():83-8. PubMed ID: 2441048 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of a commercial immunoblot assay for myositis antibody testing. Bundell C; Rojana-Udomsart A; Mastaglia F; Hollingsworth P; McLean-Tooke A Pathology; 2016 Jun; 48(4):363-6. PubMed ID: 27114370 [TBL] [Abstract][Full Text] [Related]
23. A gene expression approach to study perturbed pathways in myositis. Greenberg SA Curr Opin Rheumatol; 2007 Nov; 19(6):536-41. PubMed ID: 17917532 [TBL] [Abstract][Full Text] [Related]
24. [Myositis specific autoantibodies as a new diagnostic criterion for idiopathic inflammatory myopathies]. Kowalska-Oledzka E; Stern LZ Neurol Neurochir Pol; 2000; 34(2):339-47. PubMed ID: 10962726 [TBL] [Abstract][Full Text] [Related]
25. Malignancy and myositis: novel autoantibodies and new insights. Selva-O'Callaghan A; Trallero-Araguás E; Grau-Junyent JM; Labrador-Horrillo M Curr Opin Rheumatol; 2010 Nov; 22(6):627-32. PubMed ID: 20827204 [TBL] [Abstract][Full Text] [Related]
26. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Benveniste O; Drouot L; Jouen F; Charuel JL; Bloch-Queyrat C; Behin A; Amoura Z; Marie I; Guiguet M; Eymard B; Gilbert D; Tron F; Herson S; Musset L; Boyer O Arthritis Rheum; 2011 Jul; 63(7):1961-71. PubMed ID: 21400483 [TBL] [Abstract][Full Text] [Related]
27. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab. Aggarwal R; Oddis CV; Goudeau D; Koontz D; Qi Z; Reed AM; Ascherman DP; Levesque MC Rheumatology (Oxford); 2016 Jun; 55(6):991-9. PubMed ID: 26888854 [TBL] [Abstract][Full Text] [Related]
28. The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies. Xu Q; Li QX; Bi FF; Duan HQ; Luo YB; Yang H Clin Rheumatol; 2021 Feb; 40(2):613-624. PubMed ID: 32671659 [TBL] [Abstract][Full Text] [Related]
29. New insights in myositis-specific autoantibodies. Ghirardello A; Doria A Curr Opin Rheumatol; 2018 Nov; 30(6):614-622. PubMed ID: 30234722 [TBL] [Abstract][Full Text] [Related]
34. Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease. Mammen AL; Casciola-Rosen L; Christopher-Stine L; Lloyd TE; Wagner KR Neurol Neuroimmunol Neuroinflamm; 2015 Dec; 2(6):e172. PubMed ID: 26668818 [TBL] [Abstract][Full Text] [Related]
35. Association between self-reported race and ethnicity and myositis-specific autoantibodies in a diverse cohort of patients with inflammatory myopathy. Beam MJ; Montgomery A; Anastasiou C; Schmajuk G Clin Rheumatol; 2023 Nov; 42(11):3043-3047. PubMed ID: 37542130 [TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Hengstman GJ; Vree Egberts WT; Seelig HP; Lundberg IE; Moutsopoulos HM; Doria A; Mosca M; Vencovsky J; van Venrooij WJ; van Engelen BG Ann Rheum Dis; 2006 Feb; 65(2):242-5. PubMed ID: 16410528 [TBL] [Abstract][Full Text] [Related]
37. An update on pathogenic mechanisms of inflammatory myopathies. Rayavarapu S; Coley W; Nagaraju K Curr Opin Rheumatol; 2011 Nov; 23(6):579-84. PubMed ID: 21960036 [TBL] [Abstract][Full Text] [Related]
38. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284 [TBL] [Abstract][Full Text] [Related]